Ann: Imugene Advances to Phase 2 in Gastric Cancer Trial, page-122

Directors are loading themselves to the brim with options ........

All looking forward to joining the $100 million plus club in OZ over the next 12 months or so

In a changing and evolving global economy one thing is for certain ...People Get Sick , unfortunately many with any one of a 100 odd types of cancer .

Biotec stocks that can and do produce real remedies and solutions will enjoy a very sustainable business future . So long as they can come up with the right solution & the directors done go too far off the rails .

IF IMU have actually worked out ( and it seems they may have ) the way to turn our own body's immune system on - ( Via their B Cell platform ) .... so that antibodies can be naturally produced ( as opposed to the very very very expensive "synthetically produced" antibodies that we are hearing a lot about ......... then these last tranche of options granted to directors will be worth many many millions of dollars .

Clearly the market doesn't really get this I think . Understandably so .....as 90% of the population dont seem to have the slightest real understanding of so many very very basic biological concept .

As real evidence and anecdotal evidence starts filtering through the system ... the latter of which will be very hard to suppress ...the market will get it.

LOL